[{"uuid": "11f6092d-0996-4fa6-ae75-883e7d607d1b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": null, "days_to_last_followup": "160", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "621e1d05-0b69-4106-8280-f6b44cbfbdaf", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": "0", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5131987d-4136-429a-b325-b1d960548271", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "1031", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "103", "end": "209", "duration": 106, "dosis": "752", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cetuximab", "start": "954", "end": "1045", "duration": 91, "dosis": "825", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "337", "end": "561", "duration": 224, "dosis": "740", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "337", "end": "561", "duration": 224, "dosis": "386", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "48", "end": "209", "duration": 161, "dosis": "756", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "954", "end": "1045", "duration": 91, "dosis": "165", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "337", "end": "561", "duration": 224, "dosis": "240", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "48", "end": "181", "duration": 133, "dosis": "160", "dosis_unit": "mg"}], "qty_radiation": 4, "radiation_details": [{"type": "OTHER", "start": "841", "end": "841", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "OTHER", "start": "1093", "end": "1093", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "EXTERNAL BEAM", "start": "898", "end": "911", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "EXTERNAL BEAM", "start": "609", "end": "622", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "d05b7bfe-47ef-4238-944c-f1f8e41b7829", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "6", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b4dc98fb-a6d0-4f0f-ae89-5e385f8c0083", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "59", "end": "212", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "59", "end": "212", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "59", "end": "212", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9e30e1f2-e73e-4eaa-86ae-165236a9be2c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "39", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4011fff8-e870-4ebd-b0dd-27c9492eb84d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b395cd45-4105-4dfb-bf65-d0f776dfa582", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "198", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "57390f5d-5fa5-48c6-ac29-3b84ec6d5709", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "61", "end": "334", "duration": 273, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "61", "end": "334", "duration": 273, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "61", "end": "334", "duration": 273, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "da1a4c53-6eaf-4bf2-8499-f43cb9a2723f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "86dd5e91-416d-4be2-b41b-aa7506157f1f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "37", "days_to_last_known_alive": null, "days_to_last_followup": "1485", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "47", "end": "229", "duration": 182, "dosis": "720", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "47", "end": "187", "duration": 140, "dosis": "153", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "47", "end": "229", "duration": 182, "dosis": "720", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "672772f0-5f9f-4076-8949-2e825bacfbea", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": "3786", "days_to_last_followup": "3786", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e67964e8-de9a-4a51-91ae-96c241a3c4b2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "172", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "34bf43d1-464d-467e-b873-05ddcd78a105", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": null, "days_to_last_followup": "437", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "5- FU", "start": "60", "end": "214", "duration": 154, "dosis": "776-804", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5- FU", "start": "60", "end": "214", "duration": 154, "dosis": "4656-4872", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "60", "end": "214", "duration": 154, "dosis": "100-170", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "60", "end": "214", "duration": 154, "dosis": "800", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "28d800b5-36e8-4806-9eee-6ba42830405d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "95", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "5-Fluorouracil + leucovorin", "start": "42", "end": "196", "duration": 154, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "157", "end": "179", "duration": 22, "dosis": "5000", "dosis_unit": "cGy"}]}, {"uuid": "c5a1c33b-0a9b-4f70-966f-7c9881f2bb7e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1503", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "67bc0032-3e25-4345-884d-4a7195fe99c7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "60", "end": "213", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "60", "end": "213", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "90", "end": "182", "duration": 92, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "49651fe3-9059-4f91-93b1-944c892df671", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "168", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b36eb2c9-b4d4-4221-aa7a-2fafc503d286", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "158", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "FLUOROURACIL", "start": "74", "end": "228", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "OXALIPLATIN", "start": "74", "end": "228", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "BEVACIZUMAB", "start": "74", "end": "249", "duration": 175, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "XELODA", "start": "245", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "BEVACIZUMAB", "start": "334", "end": "397", "duration": 63, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "466", "end": "468", "duration": 2, "dosis": "4500", "dosis_unit": "cGy"}]}, {"uuid": "1349bb5d-2f1c-439b-ab81-4384adad2151", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": null, "days_to_last_followup": "158", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "32", "end": "158", "duration": 126, "dosis": "113-189", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "32", "end": "221", "duration": 189, "dosis": "872-936", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "32", "end": "223", "duration": 191, "dosis": "5232-5616", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "32", "end": "221", "duration": 189, "dosis": "50-900", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7a1744cd-60c1-4058-9068-9b77030992bc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Ancillary", "name": "Leucovorin", "start": "23", "end": "201", "duration": 178, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "23", "end": "201", "duration": 178, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "30e5587c-406b-45a5-ba73-7852c661d7e8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bfca3acd-1940-4b6b-9569-c4e66be5ea0e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "275", "duration": 244, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "275", "duration": 244, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "31", "end": "275", "duration": 244, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "31", "end": "275", "duration": 244, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "58bcee26-759f-4cdd-94fb-a03b21a6509a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7725017f-42c1-4c59-bf6f-bd93d644059d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ac0d8f7d-116b-40f5-830e-5c00d3128a78", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "61", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dab99d9b-57c4-4e68-8879-8e1d7cb2bf42", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "335", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f2836aba-5165-4529-bfe8-44f8a5e76281", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "23", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Folfox", "start": "63", "end": "214", "duration": 151, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c558d0d8-9d2a-49fc-a0af-540c301e9a0d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "90", "duration": 59, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "90", "duration": 59, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "31", "end": "90", "duration": 59, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "23bd68b9-8fc6-48e3-9659-529948560b40", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "2835", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4a4d3ed1-2f40-4fbc-b823-6a7b959ce0e4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "12", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "30", "end": "183", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "30", "end": "183", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "30", "end": "183", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "be04eaa9-8571-41d6-b6b4-9600b4d599bf", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "644", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f89bffe3-82e6-4753-99ba-b15ffe04ec9e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3eed27e4-e8df-4a5b-a5d5-b7e41f893117", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "334", "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 7, "drug_details": [{"type": "Ancillary", "name": "leucovorin calcium", "start": "21", "end": "189", "duration": 168, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "oxaliplatin", "start": "21", "end": "189", "duration": 168, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "bevacizumab", "start": "21", "end": "266", "duration": 245, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "fluorouracil", "start": "21", "end": "266", "duration": 245, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "avastin", "start": "238", "end": "253", "duration": 15, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "capecitabine", "start": "98", "end": "113", "duration": 15, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "regorafenib", "start": "280", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "568223de-852b-422b-9e16-08f3fd3d8a85", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "672cbada-fe2c-465b-a9e2-f001f79a47d9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2cf52098-7c2b-4fbe-a5ab-f02e443c8d1e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4c90bcc4-c367-4d08-bbd6-7a9a6a84834a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "464", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1bcb7432-bb54-4030-867b-3cc9dc3f7b1a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "147", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "68", "end": "145", "duration": 77, "dosis": "664-948", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "68", "end": "68", "duration": 0, "dosis": "197", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "68", "end": "147", "duration": 79, "dosis": "3982-5688", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "68", "end": "145", "duration": 77, "dosis": "50-175", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8fb9a6fd-ebc1-4d27-aa41-4b23dc737677", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "6", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "42", "end": "196", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "665", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "665", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "665", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5FU", "start": "42", "end": "196", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "42", "end": "196", "duration": 154, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "827d39aa-55e6-437d-85ac-561d3df12a9b", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": "899", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "89b20113-f72f-4033-8a8e-912813b2dbfa", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "235", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "92d1bc21-e158-40f7-9548-4794e40eb361", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "204", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Calcium Foliatum, fluorouracilum, oxaliplatinum, dexamethassone", "start": "22", "end": "282", "duration": 260, "dosis": "Calcium Foliatum 708mg, fluorouracilum 3950mg, oxaliplatinum 150,45mg, dexamethassone 8mg", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8189c797-3709-4530-8b02-0f1c9e69fd23", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "59", "end": "1127", "duration": 1068, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "59", "end": "1127", "duration": 1068, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "59", "end": "1127", "duration": 1068, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "670", "end": "700", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "59", "end": "1096", "duration": 1037, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1bb5202e-01a0-4fe9-a3e3-595ac06ffe05", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "40bfdaf0-2b2c-429f-9781-bc5e5514dc6d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "30", "end": "334", "duration": 304, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aa11d431-aae8-4ec9-9870-87198076944c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4e8cac90-eeda-4cbf-b5ea-2c3b26045216", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "89", "days_to_last_known_alive": null, "days_to_last_followup": "61", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5b1ee4f1-5dda-4642-b5fd-4a2d21f22d96", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "60b75b3e-6838-4b23-9183-495fcf5e8a9d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": null, "days_to_last_followup": "487", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "38afad4e-2bb7-4c8f-a6e9-4053d1386d8f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "14", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "67b4a035-e1fb-4f9e-9a86-e7f726be3b36", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "61", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "926cb183-17f7-447c-9665-fa064885713e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f4df38db-4d3e-45de-931f-f7c3a8c5dc93", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": "2600", "days_to_last_followup": "2600", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2fd99692-003d-48d6-84bb-9c5fc73d7cfe", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "373e91f9-c0e2-445f-87db-428328d5a444", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "387", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b5d04108-8d6d-4ec0-bcb8-24ce3c421c77", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3e537a3a-588c-4a1d-893f-7dfb9abce851", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": "89", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "43e900d7-9f13-4271-926c-ce9dedca31a4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": "159", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "FOLFOX", "start": "56", "end": "105", "duration": 49, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "40250455-7421-43d2-9583-dc0416cb6a97", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": null, "days_to_last_followup": "320", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "62", "end": "160", "duration": 98, "dosis": "100-158", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "62", "end": "223", "duration": 161, "dosis": "50-125", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "62", "end": "223", "duration": 161, "dosis": "662-744", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5FU", "start": "62", "end": "225", "duration": 163, "dosis": "3974-4464", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "239c9966-93c1-43c3-9ec9-ca03180324de", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "247", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e51161d9-0b31-4df4-90cc-a571845bde36", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "29", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "60", "end": "820", "duration": 760, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic acid", "start": "669", "end": "820", "duration": 151, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "669", "end": "820", "duration": 151, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "881", "end": "943", "duration": 62, "dosis": "50", "dosis_unit": "Gy"}]}, {"uuid": "2b81e95f-0c81-4818-be8b-b22ad4138880", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "088c6def-2350-4db3-bb11-aca337b120ef", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "41", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5d1f82eb-a481-4fe8-95c6-486a009a9a8f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "335", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "06e5ebcc-5737-4e22-8dc9-73379352c2f2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "28", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "da283dfd-5b02-48a3-9e68-f8d05f114c2f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "59", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a6ccbb1e-cd70-4d87-b36e-f617b46bae32", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "494", "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "5FU", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5c045bec-42d0-4596-b445-31c5f652f1ea", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4e156c4c-fe69-4ab5-b16c-d03139f8586f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "821", "end": "1065", "duration": 244, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "821", "end": "1155", "duration": 334, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "821", "end": "1127", "duration": 306, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "1004", "end": "1065", "duration": 61, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "821", "end": "1127", "duration": 306, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "131b7f04-a91d-43c6-b78b-c24907f66e0d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "279", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f994912e-f907-4df0-97f1-218b71db177c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "3116", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e6bb13d1-904c-44d8-8844-c8bb8cb8c37b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "214", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 11, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "75", "end": "229", "duration": 154, "dosis": "850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "75", "end": "229", "duration": 154, "dosis": "2500-2502.1", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "75", "end": "229", "duration": 154, "dosis": "95-180", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "75", "end": "229", "duration": 154, "dosis": "850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "153", "end": "214", "duration": 61, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "IRINOtecan HCl", "start": "276", "end": "365", "duration": 89, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "BEVACIZumab", "start": "304", "end": "335", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Floxuridine", "start": "396", "end": "518", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin Calcium", "start": "396", "end": "518", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "CETUXimab", "start": "670", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "IRINOtecan HCl", "start": "670", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "da8d09a5-eca5-47d7-88ee-efda15f91d91", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "61", "end": "214", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "488", "end": "503", "duration": 15, "dosis": null, "dosis_unit": null}]}, {"uuid": "e472c463-0ee6-4dd6-ae54-03aca94eaaa9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "153", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "88566fc7-8141-41d7-b586-6ddce8a3a863", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "820c0a46-6387-4f1f-b11c-ef056d8ecec6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "62", "end": "215", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "62", "end": "215", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "62", "end": "215", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c64a970a-4225-4aaa-a947-d174fd31647e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "55cdc47c-0c5d-41b7-bd40-bae65e32cc7b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "88", "days_to_last_known_alive": null, "days_to_last_followup": "518", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "75bb5e7e-1383-4368-adbf-6035e37cab25", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "2077", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "38", "end": "192", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Other, specify in notes", "name": "Oxaliplatin", "start": "38", "end": "192", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Other, specify in notes", "name": "Fluorouracil", "start": "38", "end": "192", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Other, specify in notes", "name": "Bevacizumab", "start": "38", "end": "363", "duration": 325, "dosis": "5", "dosis_unit": "mg/kg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "16eb61a7-3be9-426e-8ed7-967cdf0d3550", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3a3b4ea2-37c1-44d3-978a-94002430186e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Ancillary", "name": "Leucovorin", "start": "11", "end": "41", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "11", "end": "41", "duration": 30, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9a5b8bbd-98da-47fc-837a-3929b11c22fd", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "1334", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0f06942d-93a4-47ff-b00f-dd79e1a112b6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "153", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a64658ba-212d-4ddd-bbde-b3f8dfd92979", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "488", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "07b4085d-4dfa-4894-a815-c251d2a2e204", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1a74a765-59eb-4478-b387-2f636914f839", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "462", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "27f4ded8-1708-4cd4-8b10-d6b9f1bc8e31", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "28", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "59", "end": "59", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic acid", "start": "393", "end": "424", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "393", "end": "424", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "393", "end": "424", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "393", "end": "393", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "393", "end": "424", "duration": 31, "dosis": "31", "dosis_unit": "Gy"}]}, {"uuid": "61368f4f-0d98-4afa-a7f2-a5252eb44920", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "808548cf-a326-4256-8328-21a482d083a8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "286", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dda84e20-daf0-40b0-9c6e-d115c512cd64", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "120", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "04babe76-741f-4d13-97ae-bc60f5769b1b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1a868322-c754-4a0c-859a-c93b4af07458", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "1466", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ec45eea6-c58d-43e7-ba54-ec114e1a2460", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a1aefe3c-b9bb-4563-89c7-fc2d372129a4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bf309206-4f8b-4f47-a1e2-9600f12c3f24", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "20", "end": "206", "duration": 186, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "20", "end": "206", "duration": 186, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "20", "end": "206", "duration": 186, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8b5cd992-80fc-4d4f-b682-8e2143662973", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1849", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "1849", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "64967aa8-700e-4ffd-9f68-111ff68fe46f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": null, "days_to_last_followup": "212", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cc8aadd3-958f-4324-9c86-ef936f064491", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "1715", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "53", "end": "196", "duration": 143, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "50", "end": "191", "duration": 141, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "53", "end": "196", "duration": 143, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4a3dddc5-23d0-4202-9f1b-364625acdbb0", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9872954d-0d7e-4069-87a4-6fb4a68a7955", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": "496", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "5FU", "start": "64", "end": "146", "duration": 82, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "XELODA", "start": "212", "end": "239", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "212", "end": "239", "duration": 27, "dosis": null, "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "64", "end": "146", "duration": 82, "dosis": null, "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "51f6c59c-c112-40a8-aa46-4e4948f81ec8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "184", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "184", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "31", "end": "184", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4be18ea7-894f-4235-8e4a-b7c326cde496", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "156", "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "XELODA", "start": "113", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cd6042e0-e047-4871-8104-2d07239ce0b7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "30", "end": "214", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "30", "end": "214", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "30", "end": "214", "duration": 184, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2546f9c9-4656-4300-9ec1-f076b4687d27", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "1126", "end": "1126", "duration": 0, "dosis": "9", "dosis_unit": "Gy"}]}, {"uuid": "20560e23-95b5-473f-a227-ccd9f37c3c45", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "93a399ab-00cb-48d5-b469-f3ae1d8f14c6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "202", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "19f16a01-6c3b-4c3b-a545-20982d31fc1d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c3c0ae3d-d34a-4981-a8f8-94839a36e937", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "635dddf9-d6bb-4702-b60b-bf024315ad31", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "5-FU", "start": "38", "end": "195", "duration": 157, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "449adac5-759e-47cd-8afb-275555ba928d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "10", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6aaaf4de-e837-4cfe-bfdf-d6e82aceeaa6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6cd32ddc-d1f6-41bc-ac05-02325310e65c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "54d97e58-7467-4eed-a2a8-cb8d95097bd1", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "145", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "198a6dc5-d33b-43b0-bbcd-8278ff8bf2d8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "107", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3fc921f5-231b-4982-ac29-f36ad82f175d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "242", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7e8a50da-e5b9-4d14-b0ba-d12aeaeec97c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "475", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a9fbcec9-4048-4276-8611-e843f2f8caf2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "91", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "189e2655-ea8f-41a1-b9fd-e91128baedea", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "98396bb0-34f2-44c6-80ac-3c1fe7e43d2f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 15, "drug_details": [{"type": "Chemotherapy", "name": "Irinotecan", "start": "42", "end": "158", "duration": 116, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "42", "end": "158", "duration": 116, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "42", "end": "158", "duration": 116, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Mitomycin", "start": "173", "end": "263", "duration": 90, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Capecitabine", "start": "173", "end": "263", "duration": 90, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "361", "end": "412", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Capecitabine", "start": "361", "end": "412", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "641", "end": "760", "duration": 119, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "641", "end": "760", "duration": 119, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Camptosar", "start": "641", "end": "760", "duration": 119, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "641", "end": "760", "duration": 119, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "760", "end": "883", "duration": 123, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "1161", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Capecitabine", "start": "1161", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "1161", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "77638e18-72fa-49f6-9416-81ac08a45607", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": null, "days_to_last_followup": "534", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Other, specify in notes", "name": "Folinic Acid", "start": "448", "end": "448", "duration": 0, "dosis": "200", "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "448", "end": "448", "duration": 0, "dosis": "600", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "448", "end": "448", "duration": 0, "dosis": "85", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c9c56db8-7774-4860-bafa-3aa01404d9cb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bba837ce-c085-4883-ae41-c32368654cca", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "447", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "5- FU", "start": "76", "end": "111", "duration": 35, "dosis": "461-576", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5-FU", "start": "76", "end": "113", "duration": 37, "dosis": "2765-3456", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "76", "end": "111", "duration": 35, "dosis": "116-122", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "76", "end": "111", "duration": 35, "dosis": "550-600", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d7f7e830-f86b-4254-b45f-8bbd59324a75", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "2289", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 15, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "33", "end": "103", "duration": 70, "dosis": "400", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "1041", "end": "1181", "duration": 140, "dosis": "445", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "1377", "end": null, "duration": "", "dosis": "712", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "33", "end": "103", "duration": 70, "dosis": "400", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "2450", "end": null, "duration": "", "dosis": "168", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "33", "end": "103", "duration": 70, "dosis": "85", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "1687", "end": "2373", "duration": 686, "dosis": "300", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Cetuximab", "start": "565", "end": "726", "duration": 161, "dosis": "760", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Xeloda", "start": "1377", "end": "1636", "duration": 259, "dosis": "3600", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "565", "end": "719", "duration": 154, "dosis": "342", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "1041", "end": "1181", "duration": 140, "dosis": "800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "1041", "end": "1181", "duration": 140, "dosis": "800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "1041", "end": "1076", "duration": 35, "dosis": "170", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "2450", "end": "2450", "duration": 0, "dosis": "792", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "33", "end": "103", "duration": 70, "dosis": "5", "dosis_unit": "mg/kg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e9ca41fc-6708-403b-b9a1-13b5381513d1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fe533fd3-919b-4083-adbc-06cfcf18ec8f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "1395", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "74079c02-a77b-4a38-9010-fd86374e515b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "154", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ac235803-ff62-4fe0-9c36-397f58c9bf93", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "2775", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c453447f-3b8f-4ddb-8cf4-5a84b46f4f1b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "572", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "103", "end": "257", "duration": 154, "dosis": "824", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "103", "end": "257", "duration": 154, "dosis": "824", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "103", "end": "243", "duration": 140, "dosis": "175", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "802a82a3-7034-49ae-817b-c14ea5214843", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "523", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 10, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Avastin", "start": "90", "end": "237", "duration": 147, "dosis": "440", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Levcovorin", "start": "75", "end": "237", "duration": 162, "dosis": "800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "75", "end": "237", "duration": 162, "dosis": "800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "75", "end": "237", "duration": 162, "dosis": "170", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "75", "end": "239", "duration": 164, "dosis": "4800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "761", "end": "944", "duration": 183, "dosis": "173-177", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "761", "end": "944", "duration": 183, "dosis": "812-832", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "761", "end": "946", "duration": 185, "dosis": "4872-4992", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "761", "end": "944", "duration": 183, "dosis": "400-448", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "761", "end": "944", "duration": 183, "dosis": "50-800", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b014d68a-e0ec-4943-9b96-57dbe9211594", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "244", "end": "456", "duration": 212, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "275", "end": "306", "duration": 31, "dosis": "50", "dosis_unit": "Gy"}, {"type": "External", "start": "275", "end": "306", "duration": 31, "dosis": "50", "dosis_unit": "Gy"}]}, {"uuid": "4b2da39d-1732-4592-aaf7-d45ec0afdc29", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "070b71ef-6ded-468e-8932-d2367259d2a9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0626bbf6-749a-4660-a691-2d1c4b013f27", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "1112", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "36", "end": "148", "duration": 112, "dosis": "152", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "36", "end": "190", "duration": 154, "dosis": "400", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "36", "end": "190", "duration": 154, "dosis": "400", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ef3b8579-2bd3-40f8-adea-0a3ba8803f7f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "503", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7d61e8f6-ce8a-4e32-b4e1-7e9d172be990", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "182", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "61", "end": "135", "duration": 74, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "avastin", "start": "192", "end": "302", "duration": 110, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "avastin", "start": "61", "end": "135", "duration": 74, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "leucovorin", "start": "192", "end": "302", "duration": 110, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "192", "end": "302", "duration": 110, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "irinotecan", "start": "192", "end": "302", "duration": 110, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "leucovorin", "start": "61", "end": "135", "duration": 74, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "fluorouracil", "start": "61", "end": "135", "duration": 74, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "106", "end": "118", "duration": 12, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "d0843941-3771-4fd7-9821-5659c0175758", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "10", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "128", "end": "318", "duration": 190, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "128", "end": "318", "duration": 190, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "128", "end": "318", "duration": 190, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5a1cd61f-87a2-4bc9-b81d-eff6143fd7bc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "da2b71df-b54a-41a0-baea-75b7dc2a076c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "254", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a40178a4-fbe5-4623-a0a8-68de20fcb31e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "732f7ed0-7451-4e8f-a5b4-267bd4eda063", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "741", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "eca70649-15f6-4850-9104-0501553ad97b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7aaa951b-c5ac-46f0-b2d1-2a9ca62913b6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "28", "end": "218", "duration": 190, "dosis": "1000-1070", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "28", "end": "211", "duration": 183, "dosis": "177-182", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "28", "end": "218", "duration": 190, "dosis": "50-200", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "96e7a631-4f94-475a-b19e-64c92c4b040d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ac91170b-c84e-405d-ba1c-ee846c072e55", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "853", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "849b2829-270e-4322-ac34-b2ed2db9c879", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1bc74154-eb7d-4ab9-9a26-a7a4b1b3cced", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "515", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9dd741a8-9425-4888-a4f0-efe375e70b88", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "894", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "47", "end": "201", "duration": 154, "dosis": "800", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "47", "end": "201", "duration": 154, "dosis": "800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "47", "end": "201", "duration": 154, "dosis": "170", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "923adf89-c3ee-4c8a-9eb3-69e1ca357842", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "06aed31b-d93a-4b30-abc4-7eb79904a7fd", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "524bcdc9-2db6-4aaa-ba09-e67e9490a69d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "22", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d774996f-3029-4fce-aa7e-fee9293a44bb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b6e55cf8-0c20-4173-be93-fea71a24a0ca", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "442", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "59e02870-00d2-41c2-a03a-591f9d4f2e98", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1b02c63d-773b-43c4-8c29-71c7392f81b8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "158", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "55c88745-0b8c-485d-976d-086c805169ef", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "97", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f4a9209a-8b4f-4dd5-aefa-635084ffff81", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "13", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d188bc7f-4797-4df4-8340-1bb67643bab9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1aceb4da-b8e8-4fda-9df1-236ab606bbf8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": "1705", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Folfox", "start": "22", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": "22", "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "4bff5dd7-3927-4481-aa3c-475d74ed0b19", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c612239c-5a5d-41f1-ba7e-39acd0a666a6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b136f17c-6723-4d03-bc47-bafeaef5c938", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "183", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "fluorouracil", "start": "122", "end": "273", "duration": 151, "dosis": "600", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "fluorouracil", "start": "122", "end": "273", "duration": 151, "dosis": "1700", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin Calcium", "start": "122", "end": "273", "duration": 151, "dosis": "600", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9a4f0a64-bd04-43bb-9ef0-dcc274b9be97", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "49", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d984bf86-d803-45d0-a6f2-44a4c8cd1c93", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "1606", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "55832fac-13e4-4e51-bc8d-e51b6e6855f3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "117", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "105", "end": "245", "duration": 140, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "105", "end": "272", "duration": 167, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "105", "end": "272", "duration": 167, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "105", "end": "274", "duration": 169, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5500408b-8e8c-4e14-af2d-c8f9b3979ab5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "db14599a-d080-4205-b44a-427dc3160057", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cc429783-1817-4f82-a07a-4ac76c7e104d", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "40", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin, Folinic acid, Fluorouracil", "start": "67", "end": "195", "duration": 128, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9cb6a3bf-fb33-4426-a34f-80657ef94dc3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5491270c-9e70-464a-95a5-b31ae498dc7b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": null, "days_to_last_followup": "1386", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "73", "end": "254", "duration": 181, "dosis": "3600", "dosis_unit": "mg/day"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "78070bc0-43f3-49e8-846e-44ce4df0313d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "342", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "82", "end": "243", "duration": 161, "dosis": "50-800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "82", "end": "201", "duration": 119, "dosis": "131-173", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5FU", "start": "82", "end": "243", "duration": 161, "dosis": "804-820", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "82", "end": "245", "duration": 163, "dosis": "4824-4920", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e9de6f95-9bf7-46c2-b8a9-9faadf6c0676", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "522", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a0fa8c09-dc42-4789-b6e9-ffda1fb78504", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "62", "end": "243", "duration": 181, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "62", "end": "243", "duration": 181, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "62", "end": "182", "duration": 120, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d33a625b-6ed4-4c89-ba2b-1f003286f93b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": null, "days_to_last_followup": "244", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "49", "end": "210", "duration": 161, "dosis": "2300-4650", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "49", "end": "168", "duration": 119, "dosis": "80-165", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "49", "end": "210", "duration": 161, "dosis": "40-770", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "49", "end": "210", "duration": 161, "dosis": "400-750", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "820f16d2-6de6-4c92-ab76-7de4863f59f7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "2180", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "22646cd5-568b-44a7-8b22-f99b82554f18", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "212", "duration": 181, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "212", "duration": 181, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "31", "end": "212", "duration": 181, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "81e09b3d-447e-4984-93e5-52dab06d3b14", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "181", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9fab8e05-6ae6-4858-b15f-ce8ea971a0d4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "1227", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "FolFox", "start": "49", "end": "259", "duration": 210, "dosis": "2280", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "49", "end": "237", "duration": 188, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "49", "end": "237", "duration": 188, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "49", "end": "237", "duration": 188, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3c8d4c2b-32b1-4881-967b-48d34fb4f7f6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f64700cb-3c19-4dc3-9c4c-de2e9f361b09", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "201", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fc21d4a8-5fd4-4520-97fa-bff723035935", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1881", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7b4c0ef2-44cb-4ba7-bb1b-2464192b35ec", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "134", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "142", "end": "340", "duration": 198, "dosis": "2850-4512", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "142", "end": "338", "duration": 196, "dosis": "494-752", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "142", "end": "338", "duration": 196, "dosis": "95-150", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "142", "end": "338", "duration": 196, "dosis": "50-752", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0828a8bb-d7c7-4541-a09e-c3275be23ee7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "122", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Floxuridine", "start": "275", "end": "275", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "IRINOtecan HCl", "start": "275", "end": "306", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan HCL", "start": "17", "end": "214", "duration": 197, "dosis": "200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "30", "end": "91", "duration": 61, "dosis": "130", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Floxuridine", "start": "0", "end": "214", "duration": 214, "dosis": "170", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "98962c3c-e692-4313-88f8-a6fdaf1c9888", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0057a0e7-2a9b-4b65-929a-3d4ae903bebc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0aa88272-1ba9-4502-807d-c51065b5b785", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "43", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0675712e-ec71-4aad-95e0-9885c263e5ea", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "526", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "42", "end": "527", "duration": 485, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ebc067db-8a66-4373-8bf6-e10d0c61ac2f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "62", "end": "184", "duration": 122, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ad294f54-2373-4bfa-af95-60877aea920f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "758", "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "76", "end": "237", "duration": 161, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "76", "end": "251", "duration": 175, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "76", "end": "251", "duration": 175, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "76", "end": "253", "duration": 177, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "04aa4d5d-3ebc-418e-8e81-81346244fa4c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": "424", "days_to_last_followup": "424", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c58a3b3b-1474-4099-b286-40eecbf5ec6f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "19", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "007b27c5-d36e-4bec-9321-b03b773fd3b8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "249", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "77", "end": "247", "duration": 170, "dosis": "50-350", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "77", "end": "205", "duration": 128, "dosis": "130-164", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "77", "end": "249", "duration": 172, "dosis": "4560-4704", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "77", "end": "247", "duration": 170, "dosis": "760-784", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a9d1d4c4-a111-4f82-a66a-926ab4011fee", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "56", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "22a86401-7d2e-46ac-84da-b5b470114f88", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "295", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a9c9bc89-1223-4eee-9222-88277891a206", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "154", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "fluorouracil", "start": "22", "end": "210", "duration": 188, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "oxaliplatin", "start": "53", "end": "210", "duration": 157, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "leucovorin", "start": "53", "end": "210", "duration": 157, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "747c8e67-6a58-400c-a95b-a7275fe5d2b5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "304", "duration": 273, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "304", "duration": 273, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "31", "end": "304", "duration": 273, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f43b2574-3652-48ab-aef5-00c72161e3c5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "89", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "69b1d52d-5be7-466b-9707-9eba6239d1f1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "153", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b77d0bc2-3340-4780-a8c3-158531708bee", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "424", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5a49d9b8-c0ea-4380-8871-c578bff810ac", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "547", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "36", "end": "190", "duration": 154, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "36", "end": "190", "duration": 154, "dosis": "844", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "36", "end": "190", "duration": 154, "dosis": "844", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "128f1ea5-a82c-4f7b-894e-c130ab372fdc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": null, "days_to_last_followup": "209", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "5FU", "start": "69", "end": "286", "duration": 217, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "69", "end": "146", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "Bevacizumab", "start": "83", "end": "111", "duration": 28, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a5cdb87b-a88d-4fc4-856d-cf39a2517e33", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "61", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9d3d88f8-ba28-4163-8781-97e1a022ae79", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "61", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "61", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "61", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "61", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3e7a90bb-9dd9-4e25-a83c-725bbba53f13", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c9571f24-c16f-4486-b248-95fd1f29a2e4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0cb58018-f8ba-4469-8fa8-94b807403b89", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "61", "end": "273", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "61", "end": "153", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "214", "end": "273", "duration": 59, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Mitomycin", "start": "273", "end": "304", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "214", "end": "273", "duration": 59, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Panitumumab", "start": "273", "end": "304", "duration": 31, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "27f7abfb-9472-4ff4-b1ad-4131438c0612", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "699", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0ac86f0e-dc88-4f3f-a39f-d9a202f60e8d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "1595", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "82", "end": "110", "duration": 28, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "82", "end": "236", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "82", "end": "236", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "82", "end": "238", "duration": 156, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cetuximab", "start": "82", "end": "243", "duration": 161, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fef818d2-ac79-494a-93d1-f87838149634", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "1434", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b61200f7-0f78-4add-8a5c-c7ad3396e289", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": "3920", "days_to_last_followup": "3920", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "08ad388e-bcd4-46dd-9c97-08988908e078", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "2", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "44", "end": "227", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "44", "end": "227", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "44", "end": "227", "duration": 183, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4e13387c-c0be-4283-ad71-a73eac5850e0", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "2038", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4a483118-2d1e-483a-89e9-98ce44e92131", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "285d5557-7b55-405a-b658-9504455001f6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "669", "duration": 638, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "669", "duration": 638, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "31", "end": "883", "duration": 852, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "31", "end": "669", "duration": 638, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cetuximab", "start": "883", "end": "883", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "31", "end": "426", "duration": 395, "dosis": "39", "dosis_unit": "Gy"}, {"type": "External", "start": "365", "end": "761", "duration": 396, "dosis": "38", "dosis_unit": "Gy"}]}, {"uuid": "c8a86e45-4cac-417b-9873-dad550daa7a2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f02263eb-eb97-40ed-8237-242e4caba8e9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "802cfa2c-1ca4-4596-98cf-bc57e270de5f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "0", "age_at_initial_pathologic_diagnosis": "88", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b431f609-6e18-4232-b83a-0504496e582d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "26e15f66-e6f6-45b2-b8ff-dc8bb3d42508", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "06cf3ecb-e028-46a0-9b11-f04915b201fb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "112", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6916a9a6-a795-4f49-bcb8-2d34b1555c84", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "368", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "CPT-11", "start": "122", "end": "144", "duration": 22, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "122", "end": "144", "duration": 22, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "122", "end": "144", "duration": 22, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2180bc9c-51c9-4725-a6c7-6b7436aae439", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "921", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "C1 FOLFIRI/Zaltrap", "start": "679", "end": "756", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan + Cetuximab", "start": "343", "end": "677", "duration": 334, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "FOLFIRI/Avastin", "start": "270", "end": "334", "duration": 64, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "FOLFOX", "start": "48", "end": "210", "duration": 162, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "Internal", "start": "788", "end": "788", "duration": 0, "dosis": "568.1", "dosis_unit": "Gy"}]}, {"uuid": "9d185f05-438c-4e69-bcba-1cdca40624b5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "8", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "68", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e04f69ee-4c23-439b-8414-cb3e98e7c00a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "40", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "fluorouracil", "start": "186", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "oxaliplatin", "start": "186", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "bevacizumab", "start": "186", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ba939020-e5ac-4d9c-9515-e3de733793af", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "167", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "fluorouracil", "start": "49", "end": "476", "duration": 427, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "oxaliplatin", "start": "49", "end": "181", "duration": 132, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "bevacizumab", "start": "76", "end": "469", "duration": 393, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "bevacizumab", "start": "292", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "capecitabine", "start": "323", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f46c7d9-ee45-47e4-b1a6-130c0daecec0", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "595", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "080f872b-acbe-4e19-8bc3-6d76a73af23b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "317ba311-c6f5-4ba6-b49e-685f08128620", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "1359", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "73de597e-4f19-484b-8eab-e2876c1c26d0", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "41", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "170dafb9-eead-4af9-be31-3fb78398c49b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "61", "end": "214", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "61", "end": "214", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "61", "end": "214", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "335ebd46-0898-486d-ad6f-ac879534cbe8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "31", "days_to_last_known_alive": null, "days_to_last_followup": "130", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "5FU", "start": "60", "end": "216", "duration": 156, "dosis": "5150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "60", "end": "214", "duration": 154, "dosis": "180", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "60", "end": "214", "duration": 154, "dosis": "550", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5FU", "start": "60", "end": "214", "duration": 154, "dosis": "850", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "28322e7b-ffce-4483-95a1-262c5eb95ddb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "38", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "28", "end": "181", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "28", "end": "150", "duration": 122, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b20c9b6f-31dd-495e-a7f4-bb354b9bd79d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "2", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "164", "end": "331", "duration": 167, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "164", "end": "331", "duration": 167, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "164", "end": "331", "duration": 167, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "19", "end": "49", "duration": 30, "dosis": "5000", "dosis_unit": "cGy"}]}, {"uuid": "fc8d321c-222f-4193-a92b-5a3a2785640d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "552", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6b87cb59-a640-4596-883d-5f6ac29c768d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "17136045-60d2-48a7-a52d-a387bb55f84d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "928e4174-78bc-4911-9110-8342ef2cf7dd", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "178", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "136", "end": "276", "duration": 140, "dosis": "80-180", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "136", "end": "290", "duration": 154, "dosis": "350-850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "136", "end": "292", "duration": 156, "dosis": "4800-5100", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "136", "end": "290", "duration": 154, "dosis": "800-850", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c9452c25-6ab3-409b-a4c8-d307dd4db02b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": "3042", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3cc91b28-1f8c-4058-b60a-012d985810f8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "41", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "acd64a6c-c2de-4e3d-914c-77db4773c68d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "680", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "103", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Camptosar", "start": "100", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic acid", "start": "100", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "100", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1df1b8a0-89d4-4d1f-b7dd-0749ded8e30b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "92", "end": "184", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "92", "end": "184", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Capecitabine", "start": "184", "end": "792", "duration": 608, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "212", "end": "334", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "334", "end": "1065", "duration": 731, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cetuximab", "start": "792", "end": "1065", "duration": 273, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3fe325d0-4296-414b-a398-0e5e04384fcd", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "170", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "49", "end": "212", "duration": 163, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "Bevacizumab", "start": "49", "end": "212", "duration": 163, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "leucovorin", "start": "49", "end": "576", "duration": 527, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "fluorouracil", "start": "49", "end": "576", "duration": 527, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "96ae21fc-4d56-4274-b05f-a1a7d5757320", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "271", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "01680897-377e-4229-95fb-b17f357d0de5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fa91c256-fbfc-49c7-9310-4a7b0c0ea7bc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": null, "days_to_last_followup": "304", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 6, "drug_details": [{"type": "Other, specify in notes", "name": "Pegfilgrastim (Peg G-CSF)", "start": "91", "end": "217", "duration": 126, "dosis": "6", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "68", "end": "215", "duration": 147, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "68", "end": "229", "duration": 161, "dosis": "2000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "68", "end": "229", "duration": 161, "dosis": "650", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "68", "end": "229", "duration": 161, "dosis": "650", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Filgrastim (G-CSF)", "start": "81", "end": "81", "duration": 0, "dosis": "300", "dosis_unit": "ug"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fc05e5da-2cf7-4619-8245-d21f0d2de9a2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "246", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "XELODA", "start": "23", "end": null, "duration": "", "dosis": "500mg", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7afa7196-54ed-44b3-9a3e-5bd72d5345bf", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "91e73546-3afd-4e31-8ad0-c0d8d4ba3248", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": "108", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "21461a19-7f92-4b76-9cae-2ca5024793fd", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "214", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "56665d95-3f10-4a38-be21-af28e25618e1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "678", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "41", "end": "145", "duration": 104, "dosis": "227", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "41", "end": "209", "duration": 168, "dosis": "1068", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "41", "end": "209", "duration": 168, "dosis": "400", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ffeca3c1-dd13-4150-b80d-79c823913e07", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "2475", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "2475", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "05989205-2469-4988-816d-ca6fa07a1482", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "134", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7287fa79-19ba-4b16-b81d-312abbf9b57c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "253", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": null, "name": "Oxaliplatin", "start": "63", "end": "91", "duration": 28, "dosis": "180", "dosis_unit": "mg"}, {"type": null, "name": "Leucovorin", "start": "63", "end": "91", "duration": 28, "dosis": "840-850", "dosis_unit": "mg"}, {"type": null, "name": "Cetuximab Study drug", "start": "63", "end": "77", "duration": 14, "dosis": "1050", "dosis_unit": "mg"}, {"type": null, "name": "5 FU", "start": "63", "end": "93", "duration": 30, "dosis": "6300", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "852d5e39-a03d-4f5d-ab01-12c9d5d20a2c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2954bd36-b49f-41ba-a32f-7a0afd7456af", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "3423", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6b4c006f-7687-4e33-93e3-549fd5a3176f", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4613ef54-d6b6-4602-9315-b28af252b3ed", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "290", "age_at_initial_pathologic_diagnosis": "40", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c02388af-6997-4be6-a456-1c10f63bae92", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "202", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Calcium Foliatum, fluorouracilum, oxaliplatinum, dexamethassone", "start": "19", "end": "279", "duration": 260, "dosis": "Calcium Foliatum 768mg, fluorouracilum 3890mg, oxaliplatinum 163,2mg, dexamethassone 8mg", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "683380b2-44ef-46bb-b28f-d2de5dd5dfb1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ad0dcea7-58ed-4a8c-9bfa-3669d503eea3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "30", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "42f545c9-91a4-4a51-8115-cb6494094830", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "186", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3037daea-0c40-420f-b1f7-813fbaac27d0", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7f22c070-6fb1-4162-9cb0-13f780491d05", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "61", "end": "184", "duration": 123, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic acid", "start": "61", "end": "184", "duration": 123, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "02eb6775-d01e-474b-84ce-55f21c0eb90c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "61", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2b875031-03fd-4f2f-8dd7-1a80c5587f76", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a908ad91-01f4-450a-a9e1-c5816406303b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e0f97f6f-df9b-4119-ba11-277830231268", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "236", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "236", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c4d20ef2-67b5-4cac-b466-452190496c59", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cd39e3f8-9320-4e57-95ae-588d166d2b35", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": "3203", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "25", "end": "235", "duration": 210, "dosis": "500", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5d3d27b7-189e-4651-b243-040b05e3edb7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "46", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "726fbbb5-bd0f-452e-9fbb-691002066fac", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "60", "end": "1246", "duration": 1186, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "60", "end": "1246", "duration": 1186, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic acid", "start": "1277", "end": "1369", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluoruoracil", "start": "1277", "end": "1369", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "1277", "end": "1369", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "1246", "end": "1369", "duration": 123, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6dafe97e-9cf6-4375-b655-d214bac76a4f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "2673", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "454ab0e8-1b60-451a-a583-11c1e85644be", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "1882", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 15, "drug_details": [{"type": "Chemotherapy", "name": "5-FU", "start": "516", "end": "682", "duration": 166, "dosis": "660", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5-FU", "start": "1443", "end": "1596", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "1840", "end": "1994", "duration": 154, "dosis": "680", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Avastin", "start": "896", "end": "1443", "duration": 547, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "1840", "end": "1994", "duration": 154, "dosis": "145", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "516", "end": "682", "duration": 166, "dosis": "660", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "896", "end": "1443", "duration": 547, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "1596", "end": "1838", "duration": 242, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "1840", "end": "1994", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "896", "end": "1443", "duration": 547, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "1443", "end": "1596", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "1840", "end": "1994", "duration": 154, "dosis": "325", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Erbitux", "start": "1596", "end": "1838", "duration": 242, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "1443", "end": "1596", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "516", "end": "682", "duration": 166, "dosis": "165", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cba1818c-6265-4253-9eba-f19673ad12b2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "506", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "XELODA", "start": "89", "end": "264", "duration": 175, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "eca59413-a648-4f92-8476-23e898b9670e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": null, "days_to_last_followup": "1829", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "37", "end": "93", "duration": 56, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "37", "end": "93", "duration": 56, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "37", "end": "93", "duration": 56, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "731d77b1-cf49-4fb5-8838-6496bdf8b4f7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "182", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3aa6c927-b03d-4ebc-8b3d-b17002603822", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "1200", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8de3e610-5e2e-4ba1-84db-87e0d6c294cb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9b0705c2-873b-4801-a0df-46c1d7b7a978", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "30", "end": "242", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "30", "end": "242", "duration": 212, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ed414be3-181c-4f86-a008-12288f415517", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "2821", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": "2821", "days_to_last_followup": "2821", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "131f312b-de0d-45a9-b7b7-b1cbec8790da", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "648", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 8, "qty_drugs": 22, "drug_details": [{"type": "Other, specify in notes", "name": "Study drug AMG 655", "start": "96", "end": "270", "duration": 174, "dosis": null, "dosis_unit": "mg/kg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "96", "end": "270", "duration": 174, "dosis": "450-735", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "551", "end": null, "duration": "", "dosis": "320-325", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "96", "end": "270", "duration": 174, "dosis": "700-735", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "551", "end": null, "duration": "", "dosis": "725", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "96", "end": "270", "duration": 174, "dosis": "300-320", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "96", "end": "186", "duration": 90, "dosis": "115-155", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "551", "end": null, "duration": "", "dosis": "4300-4325", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "96", "end": "272", "duration": 176, "dosis": "2650-4400", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "551", "end": null, "duration": "", "dosis": "300-325", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "725", "end": "754", "duration": 29, "dosis": "500", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "551", "end": "754", "duration": 203, "dosis": "725", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "551", "end": "711", "duration": 160, "dosis": "300-320", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5FU", "start": "551", "end": "756", "duration": 205, "dosis": "4300-4325", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "551", "end": "739", "duration": 188, "dosis": "300-325", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "844", "end": "984", "duration": 140, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "844", "end": "844", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "844", "end": "844", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-FU", "start": "844", "end": "846", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "844", "end": "984", "duration": 140, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "1041", "end": "1105", "duration": 64, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Erbitux", "start": "1041", "end": "1091", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a972548d-d8ef-486d-a325-e7880838406a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1f59989c-f1af-467c-92c3-611e5776df48", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "182", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e74d8c54-7716-4e9e-9d14-aa66bfe19cf3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": "146", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatinum+5 fluorouracilum", "start": "48", "end": "216", "duration": 168, "dosis": "158.1+3720", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a03d9017-b159-4db9-b87d-ffea08f78052", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9bb4ded9-63de-4307-b98d-56fe4673796b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9952a109-dd29-47c4-8fda-1e285209de90", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "90", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c1ed9656-ad84-444f-a1b9-e83740ccd587", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "43", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d5a9b75d-be81-4b09-9efe-c62cc48e948d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "07cf76af-ee2e-44d3-bd35-e8a86a5c9413", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ee79a6e8-a7fc-4ea8-b9cc-ff5fed5e75a0", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "3530", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "27adba78-aad9-402f-a746-9f34cc0b07fe", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": "61", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "472daeba-30a9-41d6-aa79-c881301c8b23", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "2", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "340e6a0c-2cbc-4f52-9aa5-af41eef08656", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "4122", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2e775a0a-36db-4004-b301-d7a86b5a224b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "135", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Targeted Molecular therapy", "name": "Cetuximab", "start": "86", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "86", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "86", "end": "254", "duration": 168, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "86", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "86", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bdbd982d-558b-4d52-9237-3531794b28a6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "123", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b6ecac31-ad77-47cd-b7dd-bb755fd81f4f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "43", "age_at_initial_pathologic_diagnosis": "37", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "27", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5a1d1745-ea4a-49ec-88e8-46ca07e3381b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "427", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "427", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dbde3a52-c3f9-4fc7-b7ac-fca4efe19ac2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "173", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "72d255fa-cc76-432c-a823-5ada2e2becb2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1910", "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bbd18972-a88c-4b8c-9e44-011a218f5907", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "45", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4fdbe2e7-e183-4e1c-9b8a-1398b119e8d1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "125", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "34", "end": "181", "duration": 147, "dosis": "83-163", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "34", "end": "188", "duration": 154, "dosis": "50-175", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "34", "end": "188", "duration": 154, "dosis": "720-960", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9d9838e1-0693-4231-b840-67001be577fb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "91b289ac-95af-4697-b39a-d0db97ac005c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2aceecc3-41b6-44b4-b19a-5417f0e33986", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": "0", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aaada120-2ff0-4207-a5d3-57933c662d88", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "8", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ef417275-df4f-4c33-bd7a-aff0717f851d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": "61", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9298514d-cd86-4546-a61c-73603ccd492e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "472", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 11, "drug_details": [{"type": "Chemotherapy", "name": "Mitomycin C", "start": "443", "end": "443", "duration": 0, "dosis": "16", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "48", "end": "287", "duration": 239, "dosis": "300", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "322", "end": "350", "duration": 28, "dosis": "650", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "105", "end": "287", "duration": 182, "dosis": "275", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "322", "end": "350", "duration": 28, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "322", "end": "352", "duration": 30, "dosis": "3950", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "322", "end": "350", "duration": 28, "dosis": "650", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "48", "end": "287", "duration": 239, "dosis": "625", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Levcovorin", "start": "48", "end": "287", "duration": 239, "dosis": "625", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Avastin", "start": "322", "end": "350", "duration": 28, "dosis": "300", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "48", "end": "289", "duration": 241, "dosis": "4000", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "61cf000c-2c9b-4abd-949c-4006a2cb8b81", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "48", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e8bfca5c-d64e-4ad2-92a6-5829231bef9c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "304", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Floxuridine", "start": "31", "end": null, "duration": "", "dosis": "290", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "316", "end": null, "duration": "", "dosis": "2200", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "45", "end": null, "duration": "", "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan HCl", "start": "45", "end": null, "duration": "", "dosis": "260", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "316", "end": null, "duration": "", "dosis": "850", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Dexamethasone", "start": "78", "end": null, "duration": "", "dosis": "25", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "febbe81a-8631-4176-a5fd-9ea255b9ebc8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e929da63-206e-4bcb-aee1-20cdd25cd645", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "306", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c9a93b69-bfe9-42fc-a3cf-48ca104c2706", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "59", "end": "242", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "59", "end": "242", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "59", "end": "242", "duration": 183, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d6b8fef1-8696-47ed-992c-56cfd322e374", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "16", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "73", "end": "284", "duration": 211, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "439e74e5-9c89-4fa2-87c2-eb7e07a2eb83", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "41", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d4090534-17ac-4257-8a3f-b7a38df60c82", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "99dec419-6a0a-4fce-b0ab-79ab2020121d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3b9def9d-ae28-4bec-90ec-48fcdc712f19", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4efe71c7-29c4-4143-93cc-d70c630d8613", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "87", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b2d6c604-8bae-46ee-bbcc-0455bfe9aee3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": null, "days_to_death": "1162", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Mayo 425-20", "start": "45", "end": "174", "duration": 129, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "FOLFIRI", "start": "201", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "35db8ca0-9d72-47d8-8d71-52307a14b81b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0f49b012-f569-4438-b734-628f1bab69e4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "92a19b74-7b4e-40a5-ba08-d83a5fee30b7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1348", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": "1348", "days_to_last_followup": "1348", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b9171bfc-cf16-4ea7-8213-e4c5ebf4f6a7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "244", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Other, specify in notes", "name": "Pegfilgrastim", "start": "114", "end": "254", "duration": 140, "dosis": "6", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "98", "end": "252", "duration": 154, "dosis": "410-850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "98", "end": "225", "duration": 127, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "98", "end": "252", "duration": 154, "dosis": "2500", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "98", "end": "252", "duration": 154, "dosis": "410-850", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2d64c8f7-9e01-44cb-82d2-5e6b07376448", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "957", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aeb2b41c-0e06-4300-b7ce-eb1afd6cd511", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": "3625", "days_to_last_followup": "3625", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "10296092-6f50-4d5a-bfa4-bda6bc5ba9d9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8929c89a-902d-428b-9144-55f40a21fd4d", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": "383", "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": "383", "days_to_last_followup": "383", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "25537907-b207-4b6b-a24a-8b565148dadc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "570", "age_at_initial_pathologic_diagnosis": "88", "days_to_last_known_alive": "570", "days_to_last_followup": "570", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fa975b33-9592-4c54-9d60-586c357237e4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9d207c4e-cd7a-4116-bb95-f84fc275e86d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "30", "end": "242", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "30", "end": "242", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "30", "end": "61", "duration": 31, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bec87195-b633-42c0-b191-34c4c95a72f8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": null, "end": "31", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6dc06ab7-c02f-4f1f-8e7b-c908f4ab210d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "287", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "5-FU", "start": "539", "end": null, "duration": "", "dosis": "425", "dosis_unit": "mg/m2/day"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1e6fa187-25e1-4862-838f-c1905cb739fb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dff761b4-f975-45a9-8472-4177d3916a0a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fafccb32-c7ee-427b-b1d8-6319bb661c53", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "16", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "29", "end": "111", "duration": 82, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ac8ac74e-f4be-4bb9-a5b9-c82162d61076", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "61", "end": "243", "duration": 182, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "61", "end": "243", "duration": 182, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "61", "end": "243", "duration": 182, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5abe8e06-d57b-49f9-841e-741bca09c88a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "0", "end": "183", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "0", "end": "183", "duration": 183, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "0", "end": "183", "duration": 183, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d77f9ee9-1867-4100-ab25-e972e995bcc6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "137", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8d9cdaae-2641-4e08-8c44-57d0d3eb2c17", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "51181307-4afd-49ae-b27e-5e11070f8f87", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ab105b58-4c1b-4c11-8669-e60739a6bd84", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "30", "end": "212", "duration": 182, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "30", "end": "212", "duration": 182, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "30", "end": "153", "duration": 123, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "36ec7c22-9c58-4916-b965-9e6ed3404887", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "1631", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "46", "end": "258", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "46", "end": "258", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "46", "end": "258", "duration": 212, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2bb30a47-b00b-405a-8c86-ff9aa1276218", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "122", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "970a7c2f-7230-42ef-8a0c-6e9f50648187", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a16ed580-9bf8-4737-82d8-f2f489de08c1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": "206", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "64539b00-02e4-4e4f-af49-d493f726aec3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "821", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "72", "end": "174", "duration": 102, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5f647bac-e5c0-4c7a-a948-ecb65761f076", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "333", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "74", "end": "242", "duration": 168, "dosis": "360-925", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5-FU", "start": "74", "end": "242", "duration": 168, "dosis": "360-925", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "74", "end": "242", "duration": 168, "dosis": "100-195", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "74", "end": "244", "duration": 170, "dosis": "2150-5500", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7f592ccc-a93d-40a5-abe1-700307896393", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "743", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0b182114-e1e9-4121-83db-f8c37f6dac8c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "243", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "89", "end": "243", "duration": 154, "dosis": "850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "89", "end": "243", "duration": 154, "dosis": "2600", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "89", "end": "243", "duration": 154, "dosis": "850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "89", "end": "159", "duration": 70, "dosis": "180", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ba9f25dd-7c32-41da-9e90-63cf7cfc9177", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "670", "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8efcdaa0-56e4-47f0-9f50-e30526e3ac98", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "231", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "5 FU", "start": "50", "end": "197", "duration": 147, "dosis": "546-752", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "50", "end": "199", "duration": 149, "dosis": "3276-4512", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "50", "end": "197", "duration": 147, "dosis": "77-160", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "50", "end": "197", "duration": 147, "dosis": "50-750", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "938e96fe-3dcb-4e6f-9498-bfcd95df562a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "36", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "297a6176-e560-4a0c-b129-9f9069902dcf", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "937", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "40", "end": "180", "duration": 140, "dosis": "672", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Bevacizumab", "start": "40", "end": "180", "duration": 140, "dosis": "298", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "40", "end": "138", "duration": 98, "dosis": "143", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d3394b78-a270-4eae-8dc1-226f15c59b0b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "16", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0a436729-33c6-4a14-85f3-9d8ff95d99c2", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "456", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0754e865-891c-4ae4-9c12-bdee375afb82", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "90", "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ee20be68-38ce-4514-87b1-282665b40e2d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "867cf266-3278-4eb4-bbaa-d33c43d1b7d4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b3f78747-6bec-4f4a-bc84-bafcb5b2ae06", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "184", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "108", "end": "235", "duration": 127, "dosis": "1500", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "874d73db-1ac2-4263-8c36-c08bd4ed57ac", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a716e6da-320a-4db3-8c9d-69b1ca5f6136", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": null, "days_to_last_followup": "297", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "60", "end": "368", "duration": 308, "dosis": "143-171", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "60", "end": "395", "duration": 335, "dosis": "389-436", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "60", "end": "395", "duration": 335, "dosis": "487-804", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "60", "end": "395", "duration": 335, "dosis": "50-100", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Xeloda", "start": "426", "end": "487", "duration": 61, "dosis": "3500- 4000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "60", "end": "397", "duration": 337, "dosis": "2923-4824", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8d2ba433-2b16-45af-aac1-874aecd9695f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b4432c4b-6881-4f1e-a190-d4efdf203179", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage III", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "215", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "215", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "31", "end": "215", "duration": 184, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e10cceca-104f-4782-8a81-e02a0a9452ef", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f2850e9d-d2d3-424e-8bac-5b46ccb44d94", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2ae825a2-9941-4650-9822-46ec780704cf", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "61", "end": "213", "duration": 152, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "61", "end": "213", "duration": 152, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "61", "end": "213", "duration": 152, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cd2c6406-c2da-4f0f-bdcd-5427cd8f7c9f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "125", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2b662361-dfcc-410f-96b7-7493134e22f6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0efd65ae-8ed4-4ed5-bec6-3e53884fccc4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7a891601-c167-4fd6-80f2-5977eec5a83d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": "228", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": "228", "days_to_last_followup": "228", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b07ca5cf-8c34-456b-a59a-899e92409a32", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "286", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d878a8c2-3331-4028-85d8-0dba4ae84ac7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": "0", "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Irinotecan", "start": "0", "end": "0", "duration": 0, "dosis": "176", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Erbitux", "start": "0", "end": "0", "duration": 0, "dosis": "440", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cabc636a-6c5b-41fb-a99e-efc001c743b7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "169", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "5FU", "start": "73", "end": "246", "duration": 173, "dosis": "2800", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "73", "end": "246", "duration": 173, "dosis": "85", "dosis_unit": "mg/m2"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "73", "end": "246", "duration": 173, "dosis": "200", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1f9290af-a451-4767-8de1-6831ac5dd635", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1094", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "1094", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "27ca49a7-90fa-40f3-b05a-dde83c480869", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "241", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3f71b9c7-7668-4038-82ca-5c6bc8de3c2c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Folinic acid", "start": "31", "end": "305", "duration": 274, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "305", "duration": 274, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "31", "end": "305", "duration": 274, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": null, "end": "305", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "76ea0013-734e-4936-959a-cbda0aaba0a4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "891a8b7e-f8c7-438c-9a3a-c0247cd8e137", "tumor_tissue_site": "Colon", "pathologic_stage": null, "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "24", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0c3c3bb7-7b28-4816-b4f2-82865e189ff9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "304", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "86", "end": "240", "duration": 154, "dosis": "140", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "86", "end": "240", "duration": 154, "dosis": "650", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Pegfilgrastim", "start": "229", "end": "229", "duration": 0, "dosis": "6", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin Calcium", "start": "86", "end": "240", "duration": 154, "dosis": "650", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "86", "end": "240", "duration": 154, "dosis": "1900", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0ed6357d-9f16-4a42-900d-6743b6fe85c6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "122", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fa822343-70dd-4318-be89-a41bd5c72bc3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8ce88a20-4037-431f-babc-a0123a2c40e1", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a8c4949c-fdc2-48f6-90e2-440cc14072e7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2ee8cfca-374c-4200-96b0-e1d14d6111f9", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aa21e53e-a3b9-4329-b09f-145a239e77ca", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "669", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aeeb464f-b108-4087-b8f2-a535125a4a0d", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d4d9cddd-258d-4aa9-b9b7-83b620bfc8ca", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": "643", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8396fc81-a3d4-45f9-b2b5-0d74d6ad1427", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": "0", "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": null, "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9797ab54-54be-4f40-a315-9666391a467c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "1205", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "5-FU", "start": "34", "end": "76", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Xeloda", "start": "90", "end": "132", "duration": 42, "dosis": "3000", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "5-FU", "start": "153", "end": "194", "duration": 41, "dosis": null, "dosis_unit": null}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "34", "end": "76", "duration": 42, "dosis": "840", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "153", "end": "194", "duration": 41, "dosis": "800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "34", "end": "76", "duration": 42, "dosis": "180", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "153", "end": "194", "duration": 41, "dosis": "170", "dosis_unit": "mg"}], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "90", "end": "132", "duration": 42, "dosis": "5400", "dosis_unit": "cGy"}]}, {"uuid": "20486cee-6fa7-417f-9660-0ae7600de79c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "39", "days_to_last_known_alive": null, "days_to_last_followup": "150", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "03f0f710-8114-49da-9c42-8c9d47823a67", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "89", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2c9cdb5e-9f40-4c26-8d3f-816c7590c8d2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "212", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6191d16d-bda6-4796-899a-7c5317bde8f8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "858", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 10, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "1", "end": "349", "duration": 348, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "535", "end": "699", "duration": 164, "dosis": "55", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "1", "end": "349", "duration": 348, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Erbitux", "start": "819", "end": "846", "duration": 27, "dosis": "560", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "1", "end": "349", "duration": 348, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin", "start": "535", "end": "699", "duration": 164, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Avastin", "start": "1", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "699", "end": "699", "duration": 0, "dosis": "125", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Erbitux", "start": "699", "end": "699", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "535", "end": "699", "duration": 164, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "badec07e-d488-4b8a-9f90-3f61d5fb5b7b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dfa7126a-c6db-4c9f-b542-4f4e8c6b28b8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "91", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2d250369-7a63-47be-8cc6-fa4128a83362", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "153", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "084c576a-96a9-4d92-a32d-8aebd8041563", "tumor_tissue_site": null, "pathologic_stage": "Stage I", "histological_type": null, "days_to_death": "29", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4574fb66-844c-4bf3-a890-accbc8f9e095", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "367", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "40", "end": "54", "duration": 14, "dosis": "1000-1050", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "40", "end": "54", "duration": 14, "dosis": "1000-1055", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "40", "end": "54", "duration": 14, "dosis": "178-179", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f53a57ef-6d2c-4807-9d76-2391fb5fe873", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "106984b5-b543-404c-ad59-32ccba8c3e16", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "244", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d3ee7db9-bf2f-4495-b76f-38d626562d89", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "362", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 14, "drug_details": [{"type": "Chemotherapy", "name": "Irinotecan", "start": "301", "end": null, "duration": "", "dosis": "320-331", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "301", "end": null, "duration": "", "dosis": "50-150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "231", "end": "275", "duration": 44, "dosis": "4392-4416", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "231", "end": "273", "duration": 42, "dosis": "50-100", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "301", "end": null, "duration": "", "dosis": "339", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "301", "end": null, "duration": "", "dosis": "736", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "231", "end": "273", "duration": 42, "dosis": "150", "dosis_unit": "mg"}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "231", "end": "259", "duration": 28, "dosis": "334-343", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "301", "end": null, "duration": "", "dosis": "4416", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "301", "end": "635", "duration": 334, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "301", "end": "391", "duration": 90, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Leucovorin", "start": "301", "end": "635", "duration": 334, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "301", "end": "635", "duration": 334, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "301", "end": "637", "duration": 336, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f5045bbe-b050-45fd-b432-9a7660b38e03", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "741657d1-1b14-4922-9301-7e3c965b54d6", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "35", "days_to_last_known_alive": null, "days_to_last_followup": "153", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 10, "drug_details": [{"type": "Chemotherapy", "name": "Fluorouracil", "start": "24", "end": "184", "duration": 160, "dosis": "2800", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin Calcium", "start": "24", "end": "184", "duration": 160, "dosis": "900", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "24", "end": "150", "duration": 126, "dosis": "190", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Pegfilgrastim", "start": "54", "end": "152", "duration": 98, "dosis": "6", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "337", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "IRINOtecan HCl", "start": "337", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Leucovorin Calcium", "start": "337", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cetuximab", "start": "366", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Floxuridine", "start": "337", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "24", "end": "178", "duration": 154, "dosis": "900", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e8fecfa9-4fb7-4c07-98ea-d32e3755e773", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "510a7fd4-e030-4467-8c60-adf2c6a54c26", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "113", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c5477e2e-d074-4c6c-b72b-283c714375ae", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "95cffa41-fe32-47b9-af8d-b3bed001048e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "207", "end": "238", "duration": 31, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "24b0f7f9-0044-4762-82f7-8f1c53083b70", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "010b815e-525d-44af-826c-546afc82b277", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0b23c173-a03a-4826-8be7-64dc0357d2b5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9c240786-42e7-4f89-9488-2d0a981e93bd", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "203", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "49518421-c35a-4017-ba3b-825ca79f7230", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d5293705-1081-49f5-86fe-ae4e85eb41b7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0aaaf548-22e8-444b-8676-88b0ef215086", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": null, "days_to_last_followup": "5", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "50", "end": "204", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "50", "end": "204", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "50", "end": "204", "duration": 154, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "41653910-cc57-49f0-a030-70a9592f48c2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "449", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9d7af2cc-6a82-48da-8312-58d13d1c0bc4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": "805", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "805", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f6659450-7fca-48d8-b1d2-a30817f079bb", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "47", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "AMERICAN INDIAN OR ALASKA NATIVE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fae909c6-60cc-43cb-ba90-1a1da91df325", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "31", "end": "245", "duration": 214, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1218edda-47dc-4abc-bf07-26a313da6043", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "14", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4807dce1-3560-455d-bd5c-d5451e21e11c", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "441", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f7c7c372-9637-4142-9e06-cfad4b69d035", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "1720", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Xeloda", "start": "42", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d2adf133-3505-456b-a2ef-41a25973d88a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": null, "days_to_last_followup": "304", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "57", "end": "211", "duration": 154, "dosis": "850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "57", "end": "211", "duration": 154, "dosis": "850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "57", "end": "211", "duration": 154, "dosis": "2602.17", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "57", "end": "197", "duration": 140, "dosis": "180", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f9753058-0e9f-44b8-8752-2d6008ec4a53", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0dc8c078-aedd-4132-b1ac-a34c24f54a90", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "153", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2b00072a-55f9-48f6-a66d-941cc9b657b4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "357", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Folfiri", "start": "59", "end": "103", "duration": 44, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5 FU", "start": "165", "end": "165", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e61c2167-5363-4618-b0c0-7c91b47930fc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "3429", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "473ca1e7-da7f-4ac7-bb72-f723caaab01a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "541", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "112", "end": "617", "duration": 505, "dosis": "600", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5- FU", "start": "112", "end": "617", "duration": 505, "dosis": "592-620", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5-FU", "start": "112", "end": "252", "duration": 140, "dosis": "3552-3720", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "112", "end": "252", "duration": 140, "dosis": "66-150", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "af0bb245-8133-46ba-a7d8-de0e281d23b5", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "1492", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ef4c4f15-c23b-4d1b-83e9-4be3562aef6a", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "0", "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c0f7e7e9-9df0-40cc-a109-a884d920a1c3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "60741841-e507-4f15-a4da-e676b81cd0da", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIC", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "399", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "capecitabine", "start": "42", "end": "197", "duration": 155, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "oxaliplatin", "start": "42", "end": "197", "duration": 155, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6dfc5d3a-13ee-4876-b199-c8a616887404", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "314", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "36b9b534-e3f9-41f4-a320-48a53d0e59ad", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f7b62a07-28cc-4245-92d5-52e6fb1428c4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "122", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "98721ba0-7a1a-45af-a797-00e73e57be82", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IVA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "230", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "60", "end": "251", "duration": 191, "dosis": "85", "dosis_unit": "mg/m2"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "60", "end": "251", "duration": 191, "dosis": "200", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "5FU", "start": "60", "end": "251", "duration": 191, "dosis": "2800", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b32a0ef7-7241-4970-9aca-73891f98f4a8", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "26", "end": "229", "duration": 203, "dosis": "4", "dosis_unit": "g/day"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "26", "end": "138", "duration": 112, "dosis": "150", "dosis_unit": "mg/day"}, {"type": "Chemotherapy", "name": "Raltitrexed", "start": "313", "end": null, "duration": "", "dosis": "4", "dosis_unit": "g/day"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "682cb487-a226-4e5b-a28b-8c0924c3118e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "212", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "86", "end": "240", "duration": 154, "dosis": "190", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "86", "end": "240", "duration": 154, "dosis": "850-900", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "86", "end": "240", "duration": 154, "dosis": "2700", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "86", "end": "240", "duration": 154, "dosis": "900", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "44aa67a4-df46-4123-b443-a1f97a329bf7", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "212", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Other, specify in notes", "name": "Leucovorin", "start": "89", "end": "245", "duration": 156, "dosis": "700", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "89", "end": "245", "duration": 156, "dosis": "700", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "89", "end": "245", "duration": 156, "dosis": "2100", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fd2a6e07-12e1-4a9f-9d2e-9b77ac3205f3", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a922f7ba-a57a-4e99-ab4f-16079787a541", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "8", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatin", "start": "42", "end": "226", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "42", "end": "226", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic Acid", "start": "42", "end": "226", "duration": 184, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "00b9eb65-04c6-4d62-9cf6-6b77d75ab79b", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": "179", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "56f01780-a29e-4e3f-8338-01e8853810ca", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "607", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Oxaliplatin", "start": "54", "end": "208", "duration": 154, "dosis": "150", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "54", "end": "208", "duration": 154, "dosis": "2800", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Fluorouracil", "start": "54", "end": "208", "duration": 154, "dosis": "900", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin Calcium", "start": "54", "end": "208", "duration": 154, "dosis": "900", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2631820d-e92e-4e82-ab72-77252497647e", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "260", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "oxaliplatinum+ 5-FU", "start": "502", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "acea4b6a-5a7b-4d29-a2b5-a39571b7eef2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "34ba3e35-7c40-4eaa-a7a8-f29876b31196", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": "1", "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1752dd23-7d20-4801-9a8c-8dac9de9d3fc", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "164", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "930f7627-1a86-48ad-8ed3-940fdaa494f2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "28", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e7d5d067-ff30-4930-8b39-5c4dbe5b1436", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "42", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "17e85b95-ef0b-4746-a39c-329c20bd0191", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "17", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "861e1b4d-0d8a-4b7c-b2b8-2f3e824d8328", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": "424", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 8, "drug_details": [{"type": "Chemotherapy", "name": "5 FU", "start": "231", "end": "282", "duration": 51, "dosis": "420-856", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "43", "end": "106", "duration": 63, "dosis": "400-836", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "231", "end": "282", "duration": 51, "dosis": "89-182", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "43", "end": "106", "duration": 63, "dosis": "100-178", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "43", "end": "106", "duration": 63, "dosis": "400-850", "dosis_unit": "mg"}, {"type": "Other, specify in notes", "name": "Leucovorin", "start": "231", "end": "282", "duration": 51, "dosis": "400-850", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "43", "end": "108", "duration": 65, "dosis": "2000-5000", "dosis_unit": "mg"}, {"type": "Chemotherapy", "name": "5 FU", "start": "231", "end": "284", "duration": 53, "dosis": "2500-5136", "dosis_unit": "mg"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a9a16e53-586a-4b36-a5d2-df9bce951fd2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage I", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "30", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "86f2541e-af5b-4383-bb30-d2308edc4512", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": null, "days_to_last_followup": "67", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0f808476-b3a8-4344-93d9-2c34c58bd0b2", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Mucinous Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "31", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a08a3e12-5770-49c0-85b6-9219fc2c4449", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage II", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "88", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e3a07c60-b7b0-4729-8116-1968b8a75944", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IV", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Capecitabine", "start": "92", "end": "365", "duration": 273, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Folinic acid", "start": "365", "end": "396", "duration": 31, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5-Fluorouracil", "start": "365", "end": "761", "duration": 396, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Irinotecan", "start": "365", "end": "761", "duration": 396, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Bevacizumab", "start": "365", "end": "580", "duration": 215, "dosis": null, "dosis_unit": null}, {"type": "Targeted Molecular therapy", "name": "Cetuximab", "start": "608", "end": "761", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e6bca62e-9956-4610-8e5e-46b589540b77", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "155", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9e53a9e5-b53a-4929-b852-868c89ebfe2f", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIA", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aabcb85b-a676-4bf5-83b7-204af344eac4", "tumor_tissue_site": "Colon", "pathologic_stage": "Stage IIIB", "histological_type": "Colon Adenocarcinoma", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "393", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}]